KKB Partners Author FDLI Chapter on Philip Morris USA Inc. v. FDA
The Food and Drug Law Institute recently published the latest annual installment of its popular “top cases” publication, Top Food and Drug Cases, 2016 … more
The Food and Drug Law Institute recently published the latest annual installment of its popular “top cases” publication, Top Food and Drug Cases, 2016 … more
The Food and Drug Law Institute recently published the latest annual installment of its popular “top cases” publication, Top Food and Drug Cases, 2016 … more
KKB is pleased to announce that the U.S. State Department has invited KKB partner Suzan Onel to be the keynote speaker at … more
By Celeste D. Wheeler FDA’s recent aggressive enforcement action against homeopathic teething tablets and gels brings into sharp focus the dilemma facing … more
By: Cynthia L. Meyer This week, the U.S. Food and Drug Administration (“FDA” or “Agency”) announced it is further delaying by one … more
On February 8, 2017, KKB partners Stacy Ehrlich and Will Woodlee presented a webinar on FDA ingredient listing submissions for e-liquid products. Hosted … more
As FDA has gained more experience with inspections for good manufacturing practices (GMPs) for dietary supplements, its processes have become more sophisticated. The … more
By: Suzan Onel[*] On December 13, 2016, President Obama signed the 21st Century Cures Act (Public Law No. 114-255) (“the Act”) into … more
Kleinfeld, Kaplan & Becker, LLP, (KKB) announced today that Suzan Onel has joined the firm as a partner. KKB is a Washington, … more
Kleinfeld, Kaplan & Becker, LLP has been recognized in the 2017 “Best Law Firms” rankings by the U.S. News & World Report … more